NICE approves brain cancer drug following change to cost-effectiveness thresholds Vorasidenib (Voranigo; Servier Laboratories) has been recommended for people with certain low-grade brain tumours by the National Institute for Health and Care Excellence (NICE). Final draft guidance…

First treatment approved by #NICE for adult brain tumours in England “for more than 20 years”

#vorasidenib #cancer #braincancer #neurology

MultiSearch Tag Explorer MultiSearch Tag Explorer - Explore tags and search results by aéPiot

#VORASIDENIB
multi-search-tag-explorer.allgraph.ro/advanced-sea...
#SIÂN #REEVES
multi-search-tag-explorer.headlines-world.com/advanced-sea...

bsky.app/profile/logo-ped.bsky.social

bsky.app/starter-pack...

Voranigo® (Vorasidenib) Wins Prestigious Prix Galien Awards Across Multiple Regions Voranigo® (vorasidenib) has garnered several Prix Galien awards acknowledging its significant contributions to orphan disease therapies. Discover its journey and innovations.

Voranigo® (Vorasidenib) Wins Prestigious Prix Galien Awards Across Multiple Regions #France #Vorasidenib #Suresnes #VORANIGO #Prix_Galien

Vorasidenib and APPG News - Your voice matters!

🗣️ Share your experience of vorasidenib, email Hugh: hugh@braintumourresearch.org to have your voice heard at the 20th Nov appraisal.

Read more: https://bit.ly/4qhptoT

#TogetherWeWillFindACure #BrainTumourResearch #Vorasidenib

Vorasidenib daily. Interferon every 4 weeks.
Neutrophils low, but stable.

I train very hard, not to escape, but to improve.
The system holds, but only because I keep talking, checking, adjusting.
Nothing casual about it.

It’s work.
But it works.

#Vorasidenib #astrocytoma #MPN #Besremi

Prognostic stratification of newly diagnosed IDH-mutant gliomas by [18F]fluoroethyltyrosine and [11C]methionine PET – a retrospective, bicentric cohort study AbstractBackground. Improved prognostic stratification including imaging-based parameters is needed to guide treatment decisions in IDH-mutant glioma.Metho

🧠 Treating #IDHmutant #glioma can be tricky - watch-and-wait, #vorasidenib, or radiochemo? 🤔

📚 Our new paper in #NeuroOncology shows amino acid #PET adds prognostic value in a large bi-centric cohort (n=457) at @lmu-klinikum.bsky.social & @meduniwien.ac.at. [1/2]

doi.org/p382

Vorasidenib (Voranigo): What patients need to know? - OncoDaily Learn about Vorasidenib (Voranigo), its uses in cancer, side effects, dosage, administration, and what should patients expect during treatment.

Vorasidenib (Voranigo): What patients need to know?

oncodaily.com/drugs/vorasi...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Vorasidenib #Voranigo #Astrocytoma #BrainTumors #Drugs #FDAapprovals #Oligodendroglioma

Vorasidenib (Voranigo): Uses in Cancer, Side Effects, Dosage, Expectations, and More - OncoDaily Learn about Vorasidenib (voranigo), its uses in cancer treatment, side effects, dosage, and expectations. It is used for IDH mutated brain tumors.

Vorasidenib (Voranigo): Uses in Cancer, Side Effects, Dosage, Expectations, and More

oncodaily.com/drugs/vorasi...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Vorasidenib #Voranigo #Astrocytoma #BrainTumor #Drugs #FDAapprovals #Glioma #Oligodendroglioma

Oncology Brothers: 6 new drugs in Skin Cancer, Thyroid Cancer, Sarcoma and Glioma by U.S. FDA - OncoDaily Oncology Brothers: 6 new drugs in Skin Cancer, Thyroid Cancer, Sarcoma and Glioma by U.S. FDA / AfamiCel, cancer, Cosibelimab, glioma, Lifileucel, OncoDaily,

6 new drugs in Skin Cancer, Thyroid Cancer, Sarcoma and Glioma by U.S. FDA - Oncology Brothers
@fda.gov
@oncbrothers.bsky.social

oncodaily.com/blog/oncolog...

#AfamiCel #Cancer #Cosibelimab #Glioma #Lifileucel #OncoDaily #Oncology #Sarcoma #Selpercatinib #SkinCancer #FDA #Vorasidenib

Perioperative Vorasidenib and Ivosidenib Remain Effective, Safe in IDH1+ Diffuse Glioma Perioperative vorasidenib or ivosidenib demonstrated sustained clinical benefit in patients with predominantly non-enhancing IDH1-mutant diffuse glioma.

I just came across updated data on perioperative IDHi #vorasidenib and #ivosidenib in IDH1-mutated diffuse glioma presented at #SNO24. As someone who used to be heavily involved in early clinical development I am really delighted to see continuing progress. www.onclive.com/view/periope...

Vorasidenib's Approval: A Landmark Development in Glioma Treatment in Asia Vorasidenib gains critical approval for use in Boao Lecheng, marking a crucial step in treating IDH-mutant gliomas for Chinese patients.

Vorasidenib's Approval: A Landmark Development in Glioma Treatment in Asia #China #Vorasidenib #IDH-mutant_glioma #Servier_China #Hainan